FDA Inspection 1160560 — Eurofins Lancaster Laboratories, Inc
The FDA completed an inspection of Eurofins Lancaster Laboratories, Inc on December 10, 2021 in Portage, MI. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- December 10, 2021
- Fiscal Year
- 2022
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Portage, MI (United States)